Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166)
Withdrawn
- Conditions
- Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
- Interventions
- Other: No intervention.
- Registration Number
- NCT01293656
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Brief Summary
This study is being done to assess the clinical course and treatment options for Crohn's Disease (CD) and ulcerative colitis (UC) in the populations of Eastern Europe, Middle East, and North Africa.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Confirmed diagnosis of Crohn's disease or ulcerative colitis.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description CD and UC participants No intervention. All participants with CD or UC visiting their physician over a period of one year, newly and already diagnosed, regardless of treatment pattern.
- Primary Outcome Measures
Name Time Method The number of participants with different degrees of CD and UC severity. 1 Year Use rates of classes of drug therapy. 1 Year Number and types of surgical interventions. 1 Year The number of participants with Crohn's Disease (CD) or ulcerative colitis (UC) who visit the participating sites. 1 Year Outcomes of surgical intervention. 1 Year
- Secondary Outcome Measures
Name Time Method